Gastrointestinal Drugs Market: Global Industry Analysis, Trends, Market Size &

Forecasts to 2023
The report on Gastrointestinal Drugs Market by Infinium Global Research analyzes over the period of 2017 to
2023. This report also provides detailed qualitative and quantitative analyses of the market dynamics, market
size and future trends in Global Gastrointestinal Drugs Market. It will help a lot of decision makers to develop
strategies and find new opportunities in the Global Gastrointestinal Drugs Market.

The report on global Gastrointestinal Drugs Market provides qualitative and quantitative analysis for the
period of 2017 to 2023. According to the report the global Gastrointestinal Drugs Market value is projected to
reach USD 59.83 billion by 2023, growing with a CAGR of 4.5 % to 5.0% from 2017 to 2023. The global
Gastrointestinal Drugs Market size was totaled 46.5 Billion in 2016.

Get a Sample Report @ https://www.infiniumglobalresearch.com/Reports/MakeSampleRequest/768

Market Insights

Global gastrointestinal drugs market experienced progressive growth over the past few years. As per the
report published by world gastrointestinal organization in 2015, almost 35%-40% of worlds population is
suffering from acute and chronic gastrointestinal complications. This includes gastrointestinal disease and
disorder, due to change and dietary pattern, which is predominantly responsible for global growth of this
market. Moreover, rising prevalence of gastrointestinal disease across the globe is equally drives global
growth. Increasing investment in research and development activities in older to develop new drugs along
with growing awareness pertaining to availability of these treatments have raised considerable demand for GI
drugs. Apart from this, technological reforms in the treatment offers superior outputs and expected to
contribute significantly in the forthcoming years. The exact cause of GI related disorders are still unknown,
due to which cure for these disorders is not available. This may hamper global growth of gastrointestinal drugs
market by inviting various complications.
Segments Covered:

The report segments the global Gastrointestinal Drugs market by drug category, by route of administration, by
disease type, by end user and by region. The market size of each segment has been provided in terms of value
(USD). Market segmentation based on type of drugs category includes Acid Neutralizers, Antidiarrheal and
Laxatives, antiemetic, Anti-inflammatory, and others. Wherein acid neutralizers further sub segmented into
antacids, H2 antagonists, and Proton Pump Inhibitor. On the basis of route of administration global market has
been segmented into oral, parenteral, and rectal. Moreover, Market based on disease type includes gastro-
esophageal reflux disorder (GERD), Inflammatory bowel disease, and other, whereas, end user segment
comprises hospital pharmacies, retail pharmacies and other.

Make an Enquiry @ https://www.infiniumglobalresearch.com/Reports/MakeEnquiryRequest/768

Company Profiles

Abbott Laboratories
Allergan Plc
AstraZeneca
Bayer AG
Boehringer Ingelheim GmbH
GlaxoSmithKline Plc.
Janssen Biotech Inc.
Sanofi
Takeda Pharmaceutical
Valeant Pharmaceuticals Inc.
Key topics covered:

1. Preface

2. Executive Summary

3. Global Gastrointestinal Drugs Market Overview

4. Global Gastrointestinal Drugs Market: IGR Snapshots

5. Global Gastrointestinal Drugs by Drug Category (USD Billion) 2017 2023

6. Global Gastrointestinal Drugs Market Analysis, by Route Of Administration (USD Billion) 2017 2023

7. Global Gastrointestinal Drugs Market Analysis, by Disease Type (USD Billion) 2017 2023

8. Global Gastrointestinal Drugs Market Analysis, by End User (USD Billion) 2017 2023

9. Global Gastrointestinal Drugs Market Analysis, by Region (USD Billion) 2017 2023

10. Company Profiles

Click to View Complete Report @

https://www.infiniumglobalresearch.com/healthcare_medical_devices/global_gastrointestinal_drugs_mar
ket